The Immunofixation Profile Quantitative test in urine offered by Metropolis Healthcare measures specific monoclonal light chains with high precision, helping detect conditions such as multiple myeloma and AL amyloidosis. By quantifying abnormal proteins like Bence Jones proteins, this test provides crucial information on disease severity and kidney involvement. It is particularly useful for patients presenting with unexplained proteinuria or suspected plasma cell disorders. The results support diagnosis, monitoring, and treatment planning.
Price:
Rs. 8,350.00
Sample Type: URINE
Fasting Not Required
Booking Procedure:
- Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You can make the payment to the technician at the time of collection
- Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
- Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.
Frequently Asked Questions (FAQ's):
What does the Quantitative Immunofixation urine test include?
The test includes precise measurement of monoclonal light chains in urine to detect abnormal protein patterns.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced electrophoresis and immunochemical techniques to accurately quantify urinary light chains.
Who should undergo this test?
Patients with suspected multiple myeloma, AL amyloidosis, or persistent protein loss in the urine should consider this test.
What sample type is required for this test?
A 24-hour urine sample is preferred to ensure accurate quantification of monoclonal proteins.
How accurate are the results at Metropolis Healthcare?
Metropolis Healthcare follows strict quality standards and validated methods to deliver precise and reliable results.
Can this test detect kidney involvement in myeloma?
Yes, elevated monoclonal light chains can indicate renal damage caused by plasma cell disorders.
Is this test useful for treatment monitoring?
Absolutely, tracking protein levels over time helps evaluate treatment response and disease progression.
Does this test complement serum studies?
Yes, it is often used alongside serum immunofixation for a complete assessment of monoclonal gammopathies